ABC Family Arquivos Brasileiros de Cardiologia International Journal of Cardiovascular Sciences ABC Heart Failure & Cardiomyopathy ABC Imagem Cardiovascular
Português English
ABC Family
Português English
  • About
    • About ABC Family
    • Internal Regulation
    • Editorial Board
    • Brazilian Society of Cardiology (SBC)
  • Issues
  • SBC Guidelines
  • Content
    • Videos
    • Podcasts
    • News
  • About
    • About ABC Family
    • Internal Regulation
    • Editorial Board
    • Brazilian Society of Cardiology (SBC)
  • Issues
  • SBC Guidelines
  • Content
    • Videos
    • Podcasts
    • News

ABC Family

  • ABC Family
  • Arquivos Brasileiros de Cardiologia
  • International Journal of Cardiovascular Sciences
  • ABC Heart Failure & Cardiomyopathy
  • ABC Imagem Cardiovascular
Search in

No content found.

Journals
Ordering
Article types
Others

  1. Home
  2. Keyword: Paclitaxel
Figure 1
ABCIC
Original Article

Is Paclitaxel Less Cardiotoxic in the Treatment of Breast Cancer Before or After Doxorubicin?

André Luiz Cerqueira de Almeida et al. Edval Gomes dos Santos Júnior Aluísio José de Oliveira Monteiro Neto Thyago Monteiro do Espírito Santo … Paulo André A. Almeida Samuel Oliveira Affonseca Caroline de Souza Almeida Matheus Pamponet Freitas Cecília Lopes Viana Santos Vitória Régia Beserra Barbosa Ximenes Mariana Andrade Falcão Israel Costa Reis Suzane Pereira de Souza Maurício Gomes da Silva Serra Ana Beatriz Menezes de Oliveira Tayla Silva Santos Nilson Lima Lopes Marcelo Dantas Tavares de Melo

Abstract

Background:

The combination of doxorubicin (DOX) with paclitaxel (PTX) effectively treats breast cancer (BC). However, DOX-associated cardiotoxicity (CTX) is aggravated by the use of PTX. Consensus is lacking about which drug sequence involves the most CTX.

Objectives:

To evaluate whether DOX followed by PXT or the reverse sequence has the greatest cardiotoxic potential in the treatment of BC.

Methods:

Prospective study of women with primary BC who received four cycles of DOX and 12 infusions of PTX. Participants were divided into Group 1 (G1; PXT before DOX) and Group 2 (G2; DOX before PXT) at the discretion of the oncologist. CTX was defined as an absolute reduction in left ventricular ejection fraction (LVEF) > 10% to a value <53%. Patients underwent clinical evaluations and echocardiography before treatment (Phase 1) and one year after treatment (Phase 2).

Results:

Sixty-nine women were evaluated: 19 in G1 and 50 in G2. The groups had similar clinical characteristics. The doses of radiation, DOX, and PTX used were similar. Eight (11.6%) patients developed CTX: two (10.5%) in G1 and six (12.0%) in G2 (p=0.62). The mean LVEF was similar between groups in Phase 1 (G1=65.1±3.5%; G2=65.2±3.9%; p=0.96), with a significant reduction noted after one year in both groups: G1=61.4±8.1% (p=0.021) and G2=60.8±7.6% (p<0.001). Although lower, mean LVEF remained similar between groups after Phase 2 (p=0.79).

Conclusions:

In women with BC who underwent chemotherapy, the incidence of CTX at the end of the first year of treatment was similar regardless of whether DOX was used before or after PTX.

  • Breast neoplasm
  • Cardiotoxicity
  • Doxorubicin
  • Paclitaxel
Read Full Article
Creative Commons Attribution (CC BY) Creative Commons license
13/06/2022 DOI: 10.47593/2675-312X/20223502eabc289 Views 3
Figure 1
ABC
Original Article

Impact of Paclitaxel-Eluting Balloons Compared to Second-Generation Drug-Eluting Stents for of In-Stent Restenosis in a Primarily Acute Coronary Syndrome Population

Guillaume Marquis-Gravel et al. Alexis Matteau Brian J Potter François Gobeil … Nicolas Noiseux Louis-Mathieu Stevens Samer Mansour

Abstract

Background:

The place of drug-eluting balloons (DEB) in the treatment of in-stent restenosis (ISR) is not well-defined, particularly in a population of all-comers with acute coronary syndromes (ACS).

Objective:

Compare the clinical outcomes of DEB with second-generation drug-eluting stents (DES) for the treatment of ISR in a real-world population with a high proportion of ACS.

Methods:

A retrospective analysis of consecutive patients with ISR treated with a DEB compared to patients treated with a second-generation DES was performed. The primary endpoint was a composite of major adverse cardiovascular events (MACE: all-cause death, non-fatal myocardial infarction, and target lesion revascularization). Comparisons were performed using Cox proportional hazards multivariate adjustment and Kaplan-Meier analysis with log-rank.

Results:

The cohort included 91 patients treated with a DEB and 89 patients treated with a DES (74% ACS). Median follow-up was 26 months. MACE occurred in 33 patients (36%) in the DEB group, compared to 17 patients (19%) in the DES group (p log-rank = 0.02). After multivariate adjustment, there was no significant difference between the groups (HR for DEB = 1.45 [95%CI: 0.75-2.83]; p = 0.27). Mortality rates at 1 year were 11% with DEB, and 3% with DES (p = 0.04; adjusted HR = 2.85 [95%CI: 0.98-8.32]; p = 0.06).

Conclusion:

In a population with a high proportion of ACS, a non-significant numerical signal towards increased rates of MACE with DEB compared to second-generation DES for the treatment of ISR was observed, mainly driven by a higher mortality rate. An adequately-powered randomized controlled trial is necessary to confirm these findings.

  • Acute coronary syndrome
  • Angioplasty, Balloon
  • Coronary Restenosis
  • Drug-Eluting Stents
  • Paclitaxel
Read Full Article
Creative Commons Attribution (CC BY) Creative Commons license
28/09/2017 DOI: 10.5935/abc.20170142
ABC
Artigo Original

Rationale and design for the PAINT randomized trial

Pedro A. Lemos et al. Bruno Moulin Marco A. Perin Ludmilla A.R.R. Oliveira … J. Airton Arruda Valter C. Lima Antonio A.G. Lima Paulo R.A. Caramori Cesar R. Medeiros Mauricio R. Barbosa Fabio S. Brito Jr Expedito E. Ribeiro Eulógio E. Martinez

BACKGROUND: We describe the rationale and design for the “PercutAneous INTervention with biodegradable-polymer based paclitaxel-eluting or sirolimus-eluting versus bare stents for de novo coronary lesions – PAINT trial”. OBJECTIVES: To evaluate two novel formulations of paclitaxel-eluting stent and the sirolimus-eluting stent against a stent with the same metallic structure but without polymer coating or drug elution. METHODS: The PAINT is a multicenter 3-arm randomized trial, conducted in Brazilian tertiary institutions, which included 275 patients allocated for the InfinniumR paclitaxel-eluting stent, the SupralimusR sirolimus-eluting stent or the Milennium MatrixR bare metal stent in a 2:2:1 ratio. Patients had de novo coronary lesions in native vessels with a diameter between 2.5 and 3.5 mm, amenable for treatment with a single stent of 29 mm or less in length. The primary objetive was to compare the in-stent late loss at 9 months of both paclitaxel- and sirolimus-eluting versus the late loss of control bare metal stents. Important secondary objectives included the comparison in outcomes between sirolimus and paclitaxel stents, as well as the analysis of the incidence of major adverse cardiac events. RESULTS AND CONCLUSIONS: The PAINT trial had a unique design that allowed for the evaluation of the safety and efficacy profiles of two novel drug-eluting stent formulations, with a biodegradable-polymer carrier and releasing paclitaxel or sirolimus, which were compared against a bare metal stent (primary objective). As the drug-eluting stents differed by the drug, but were identical otherwise, the trial also allowed the comparison of the anti-restenosis effects of sirolimus versus paclitaxel (secondary objective).

  • Coronary Restenosis
  • Drug-Eluting Stents
  • Multicenter Study
  • Paclitaxel
  • Sirolimus
Read Full Article
Creative Commons Attribution (CC BY) Creative Commons license
05/05/2010 DOI: 10.1590/S0066-782X2009001200006 Views 1
Late coronary thrombosis secondary to implantation of paclitaxel-eluting stent without restenosis of conventional stents
ABC
Case Report

Late coronary thrombosis secondary to implantation of paclitaxel-eluting stent without restenosis of conventional stents

Luciano Maurício de Abreu et al. George César Ximenes Meireles Marcos Kiyoshi Sumita Antonio Artur da Cruz Forte … Jose Del Carmen Solano Aliaga Jorge Hayashi

A male 39 year-old patient with post-infarction angina. The coronary angiography showed total proximal obstruction of right coronary artery (RCA), obstructive lesions of 95% of the anterior descending artery (ADA), 80% of the second left marginal branch (LM2), and 95% of the circumflex artery (CXA). The patient was successfully implanted with a Taxus 3.0 x 24 mm stent and an Express 2.75 x 24 mm stent in the proximal and distal thirds of the RCA, respectively, and with an Infinnium 3.0 x 24 mm stent in the ADA. After seven months, the patient had an anterior acute myocardial infarct (AMI) due to thrombosis of the Infinnium stent and restenosis of the Taxus stent, with no loss of results in the conventional stents.

  • Coronary Reestenosis
  • Coronary Thrombosis
  • Paclitaxel
  • Stents
Read Full Article
Creative Commons Attribution (CC BY) Creative Commons license
15/06/2007 DOI: 10.1590/S0066-782X2007000500023 Views 1
Proximal left anterior descending coronary artery revascularization with drug-eluting stents
ABC
Artigo Original

Proximal left anterior descending coronary artery revascularization with drug-eluting stents

Jorge Humberto Guardado et al. Raúl Moreno João Costa Maria J. Perez-Viscayno … Luís Segura Fernando Alfonso Rosana Hernández Javier Escaned Camiño Bañuelos Carlos Macaya

OBJECTIVE: To assess the clinical prognosis of patients with coronary artery diseases undergoing percutaneous revascularization with drug-eluting stent implantation in the proximal left anterior descending coronary artery. METHODS: One hundred and seventy consecutive patients with mean age of 65 years, 49 of them females (29%), undergoing implantation of at least one drug-eluting stent in our medical center. The total number of drug-eluting stents implanted was 189, of which 115 (61%) were sirolimus-eluting (CYPHER TM) and 74 (39%) were paclitaxel-eluting stents (TAXUS TM). In 100 (60%) of the cases, multivessel coronary artery disease was present. In 61 (36%) patients another coronary artery segment was treated in addition to the proximal left anterior descending coronary artery. The mean clinical follow-up period was 11 ± 5 months, and angiographic controls were performed between 6 and 9 months. The final endpoint was a composite of death, acute myocardial infarction and need for reintervention on the anterior descending. The secondary endpoint included the occurrence of restenosis, need for reintervention on the proximal segment of the left anterior descending and stent thrombosis. RESULTS: The procedure achieved immediate angiographic success in all patients. Two deaths, two acute myocardial infarctions, and two percutaneous coronary reinterventions due to stent thrombosis were recorded during in-hospital stay. At the sixth month of follow-up, an additional cardiac death and three myocardial infarctions were observed; three repeat revascularization procedures were required. Up to the end of the follow-up, three additional deaths, three myocardial infarctions and eight revascularization procedures of the anterior descending, two of them surgical, were verified. Survival free from major adverse cardiac events was 91%. Cardiac mortality was 3%. Binary restenosis in the proximal segment of the left anterior descending coronary artery was 4.1%. Target vessel revascularization-free survival was 94%. No cases of late stent thrombosis were observed. CONCLUSION: Percutaneous revascularization of the proximal left anterior descending coronary artery with implantation of drug-eluting stents is a safe and very efficient therapeutic strategy in the short and long terms.

  • Angioplasty
  • Paclitaxel
  • percutaneous coronary
  • Sirolimus
  • stent
  • transluminal
Read Full Article
Creative Commons Attribution (CC BY) Creative Commons license
20/03/2007 DOI: 10.1590/S0066-782X2007000200005

How to cite this article

EndNote RIS

Electronic Document Format (Vancouver)

Almeida ALC, Santos Júnior EG, Monteiro Neto AJO, Santo TME, Almeida PAA, Affonseca SO, Almeida CS, et al. Is Paclitaxel Less Cardiotoxic in the Treatment of Breast Cancer Before or After Doxorubicin?. ABC Imagem Cardiovascular 2022;35(2):eabc289.

Electronic Document Format (ABNT)

Almeida, André Luiz Cerqueira de; Santos Júnior, Edval Gomes dos; Monteiro Neto, Aluísio José de Oliveira; Santo, Thyago Monteiro do Espírito; Almeida, Paulo André A.; Affonseca, Samuel Oliveira; Almeida, Caroline de Souza; Freitas, Matheus Pamponet; Santos, Cecília Lopes Viana; Ximenes, Vitória Régia Beserra Barbosa; Falcão, Mariana Andrade; Reis, Israel Costa; Souza, Suzane Pereira de; Serra, Maurício Gomes da Silva; Oliveira, Ana Beatriz Menezes de; Santos, Tayla Silva; Lopes, Nilson Lima; Melo, Marcelo Dantas Tavares de. Is Paclitaxel Less Cardiotoxic in the Treatment of Breast Cancer Before or After Doxorubicin?. ABC Imagem Cardiovascular, v. 35, n. 2, eabc289, Jun. 2022.

Electronic Document Format (APA)

Almeida, A. L. C. , Santos Júnior, E. G. , Monteiro Neto, A. J. O., Santo, T. M. E., Almeida, P. A. A., Affonseca, S. O., Almeida, C. S., Freitas, M. P., Santos, C. L. V., Ximenes, V. R. B. B., Falcão, M. A., Reis, I. C., Souza, S. P. , Serra, M. G. S., Oliveira, A. B. M. , Santos, T. S., Lopes, N. L., & Melo, M. D. T. (2022). Is Paclitaxel Less Cardiotoxic in the Treatment of Breast Cancer Before or After Doxorubicin?. ABC Imagem Cardiovascular, 35(2), eabc289.

Electronic Document Format (ISO)

Almeida, André Luiz Cerqueira de and Santos Júnior, Edval Gomes dos and Monteiro Neto, Aluísio José de Oliveira and Santo, Thyago Monteiro do Espírito and Almeida, Paulo André A. and Affonseca, Samuel Oliveira and Almeida, Caroline de Souza and Freitas, Matheus Pamponet and Santos, Cecília Lopes Viana and Ximenes, Vitória Régia Beserra Barbosa and Falcão, Mariana Andrade and Reis, Israel Costa and Souza, Suzane Pereira de and Serra, Maurício Gomes da Silva and Oliveira, Ana Beatriz Menezes de and Santos, Tayla Silva and Lopes, Nilson Lima and Melo, Marcelo Dantas Tavares de. Is Paclitaxel Less Cardiotoxic in the Treatment of Breast Cancer Before or After Doxorubicin?. ABC Imagem Cardiovascular [online]. 2022, vol. 35, n. 2, [cited 2026-10-14], eabc289. Available from: <https://journals.cardiol.br/en/article/is-paclitaxel-less-cardiotoxic-in-the-treatment-of-breast-cancer-before-or-after-doxorubicin/>. ISSN 2318-8219

EndNote RIS

Electronic Document Format (Vancouver)

Marquis-Gravel G, Matteau A, Potter BJ, Gobeil F, Noiseux N, Stevens L, Mansour S, et al. Impact of Paclitaxel-Eluting Balloons Compared to Second-Generation Drug-Eluting Stents for of In-Stent Restenosis in a Primarily Acute Coronary Syndrome Population. Arquivos Brasileiros de Cardiologia 2017;109(4):277-83.

Electronic Document Format (ABNT)

Marquis-Gravel, Guillaume; Matteau, Alexis; Potter, Brian J; Gobeil, François; Noiseux, Nicolas; Stevens, Louis-Mathieu; Mansour, Samer. Impact of Paclitaxel-Eluting Balloons Compared to Second-Generation Drug-Eluting Stents for of In-Stent Restenosis in a Primarily Acute Coronary Syndrome Population. Arquivos Brasileiros de Cardiologia, v. 109, n. 4, p. 277-283, Sep. 2017.

Electronic Document Format (APA)

Marquis-Gravel, G., Matteau, A., Potter, B. J., Gobeil, F., Noiseux, N., Stevens, L., & Mansour, S. (2017). Impact of Paclitaxel-Eluting Balloons Compared to Second-Generation Drug-Eluting Stents for of In-Stent Restenosis in a Primarily Acute Coronary Syndrome Population. Arquivos Brasileiros de Cardiologia, 109(4), 277-283.

Electronic Document Format (ISO)

Marquis-Gravel, Guillaume and Matteau, Alexis and Potter, Brian J and Gobeil, François and Noiseux, Nicolas and Stevens, Louis-Mathieu and Mansour, Samer. Impact of Paclitaxel-Eluting Balloons Compared to Second-Generation Drug-Eluting Stents for of In-Stent Restenosis in a Primarily Acute Coronary Syndrome Population. Arquivos Brasileiros de Cardiologia [online]. 2017, vol. 109, n. 4, [cited 2026-10-14], pp. 277-283. Available from: <https://journals.cardiol.br/en/article/impact-of-paclitaxel-eluting-balloons-compared-to-second-generation-drug-eluting-stents-for-of-in-stent-restenosis-in-a-primarily-acute-coronary-syndrome-population/>. ISSN 0066-782X

EndNote RIS

Electronic Document Format (Vancouver)

Lemos PA, Moulin B, Perin MA, Oliveira LA, Arruda JA, Lima VC, Lima AA, et al. Rationale and design for the PAINT randomized trial. Arquivos Brasileiros de Cardiologia 2010;93(6):590-7.

Electronic Document Format (ABNT)

Lemos, Pedro A.; Moulin, Bruno; Perin, Marco A.; Oliveira, Ludmilla A.R.R.; Arruda, J. Airton; Lima, Valter C.; Lima, Antonio A.G.; Caramori, Paulo R.A.; Medeiros, Cesar R.; Barbosa, Mauricio R.; Brito Jr, Fabio S.; Ribeiro, Expedito E.; Martinez, Eulógio E.. Rationale and design for the PAINT randomized trial. Arquivos Brasileiros de Cardiologia, v. 93, n. 6, p. 590-597, May. 2010.

Electronic Document Format (APA)

Lemos, P. A., Moulin, B., Perin, M. A., Oliveira, L. A., Arruda, J. A., Lima, V. C., Lima, A. A., Caramori, P. R., Medeiros, C. R., Barbosa, M. R., Brito Jr, F. S., Ribeiro, E. E., & Martinez, E. E. (2010). Rationale and design for the PAINT randomized trial. Arquivos Brasileiros de Cardiologia, 93(6), 590-597.

Electronic Document Format (ISO)

Lemos, Pedro A. and Moulin, Bruno and Perin, Marco A. and Oliveira, Ludmilla A.R.R. and Arruda, J. Airton and Lima, Valter C. and Lima, Antonio A.G. and Caramori, Paulo R.A. and Medeiros, Cesar R. and Barbosa, Mauricio R. and Brito Jr, Fabio S. and Ribeiro, Expedito E. and Martinez, Eulógio E.. Rationale and design for the PAINT randomized trial. Arquivos Brasileiros de Cardiologia [online]. 2010, vol. 93, n. 6, [cited 2026-10-14], pp. 590-597. Available from: <https://journals.cardiol.br/en/article/rationale-and-design-for-the-paint-randomized-trial/>. ISSN 0066-782X

EndNote RIS

Electronic Document Format (Vancouver)

Abreu LM, Meireles GCX, Sumita MK, Forte AAC, Aliaga JDCS, Hayashi J. Late coronary thrombosis secondary to implantation of paclitaxel-eluting stent without restenosis of conventional stents. Arquivos Brasileiros de Cardiologia 2007;88(5):e111-4.

Electronic Document Format (ABNT)

Abreu, Luciano Maurício de; Meireles, George César Ximenes; Sumita, Marcos Kiyoshi; Forte, Antonio Artur da Cruz; Aliaga, Jose Del Carmen Solano; Hayashi, Jorge. Late coronary thrombosis secondary to implantation of paclitaxel-eluting stent without restenosis of conventional stents. Arquivos Brasileiros de Cardiologia, v. 88, n. 5, p. e111-e114, Jun. 2007.

Electronic Document Format (APA)

Abreu, L. M. , Meireles, G. C. X., Sumita, M. K., Forte, A. A. C., Aliaga, J. D. C. S., & Hayashi, J. (2007). Late coronary thrombosis secondary to implantation of paclitaxel-eluting stent without restenosis of conventional stents. Arquivos Brasileiros de Cardiologia, 88(5), e111-e114.

Electronic Document Format (ISO)

Abreu, Luciano Maurício de and Meireles, George César Ximenes and Sumita, Marcos Kiyoshi and Forte, Antonio Artur da Cruz and Aliaga, Jose Del Carmen Solano and Hayashi, Jorge. Late coronary thrombosis secondary to implantation of paclitaxel-eluting stent without restenosis of conventional stents. Arquivos Brasileiros de Cardiologia [online]. 2007, vol. 88, n. 5, [cited 2026-10-14], pp. e111-e114. Available from: <https://journals.cardiol.br/en/article/late-coronary-thrombosis-secondary-to-implantation-of-paclitaxel-eluting-stent-without-restenosis-of-conventional-stents/>. ISSN 0066-782X

EndNote RIS

Electronic Document Format (Vancouver)

Guardado JH, Moreno R, Costa J, Perez-Viscayno MJ, Segura L, Alfonso F, Hernández R, et al. Proximal left anterior descending coronary artery revascularization with drug-eluting stents. Arquivos Brasileiros de Cardiologia 2007;88(2):159-66.

Electronic Document Format (ABNT)

Guardado, Jorge Humberto; Moreno, Raúl; Costa, João; Perez-Viscayno, Maria J.; Segura, Luís; Alfonso, Fernando; Hernández, Rosana; Escaned, Javier; Bañuelos, Camiño; Macaya, Carlos. Proximal left anterior descending coronary artery revascularization with drug-eluting stents. Arquivos Brasileiros de Cardiologia, v. 88, n. 2, p. 159-166, Mar. 2007.

Electronic Document Format (APA)

Guardado, J. H., Moreno, R., Costa, J., Perez-Viscayno, M. J., Segura, L., Alfonso, F., Hernández, R., Escaned, J., Bañuelos, C., & Macaya, C. (2007). Proximal left anterior descending coronary artery revascularization with drug-eluting stents. Arquivos Brasileiros de Cardiologia, 88(2), 159-166.

Electronic Document Format (ISO)

Guardado, Jorge Humberto and Moreno, Raúl and Costa, João and Perez-Viscayno, Maria J. and Segura, Luís and Alfonso, Fernando and Hernández, Rosana and Escaned, Javier and Bañuelos, Camiño and Macaya, Carlos. Proximal left anterior descending coronary artery revascularization with drug-eluting stents. Arquivos Brasileiros de Cardiologia [online]. 2007, vol. 88, n. 2, [cited 2026-10-14], pp. 159-166. Available from: <https://journals.cardiol.br/en/article/proximal-left-anterior-descending-coronary-artery-revascularization-with-drug-eluting-stents/>. ISSN 0066-782X

  • About ABC Family
  • Internal Regulation
  • Editorial Board
  • Brazilian Society of Cardiology (SBC)

Issues

SBC Guidelines

  • Videos
  • Podcasts
  • News